George Dickson is the University Chair of Molecular Cell Biology. He is a past President of the ESGCT, founder member and past Secretary of the BSGCT, and a former member of the EMA-CAT. He has spent most of his career studying neuromuscular disease, and Duchenne muscular dystrophy (DMD) in particular. His contributions include:
- Cloning of an intact healthy dystrophin gene, and subsequent development of gene therapies for DMD and OPMD.
- Discovery of exon skipping as a treatment strategy for DMD, subsequent development of clinical morpholino reagents, and more recently of antisense strategies for FSHD, and against the myostatin gene.
- Description of DMD genome editing and dystrophin gene correction using engineered endonucleases.